Dublin, Feb. 27, 2019 (GLOBE NEWSWIRE) -- The "Genome Editing: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

This study is focused on the market side of genome editing and provides a comprehensive review of genome editing technologies, along with updates on the latest related progress in the field. Different market segments for this specific market are covered. For example, application-based market segments include academic research, drug development, clinical therapy, non-transgenic breeding and other applications; and regional market segments.

Specifically centered on the market itself and its environment, this report covers almost all aspects of the global genome editing industry, including its technologies, applications and markets, which are further segmented and analyzed by region, product type, application and technology.

The report forecasts the sizes and trends of the global market as well as each of its segments. It details recent technical breakthroughs as well as major technical issues to overcome before genome editing is applied to clinical applications. The growth driving factors and the factors that may limit the market's growth are identified. The ethical issues, regulatory issues and intellectual property rights issues are discussed. The trends of patent publications, research publications and research funding in the genome editing area are analyzed.

A competitive landscape, including various growth strategies and opportunities, are discussed. Comprehensive company profiles of the major players in the current genome editing field are also included in this report. In addition, the contract services market and clinical applications market are also discussed.

The Report Includes:

• A comprehensive overview of the global markets and technologies for genome editing within the industry
• Analyses of global market trends, with data from 2017, 2018, and projections compound annual growth rates (CAGRs) through 2023
• Segmentation of the global market by geographical regions, product types, technology types and end-user application areas
• Emphasis on the market size and segmentation of gene editing products, including gene editing tools, cell lines, animal models and potential clinical products
• Current status on the intellectual property right of the CRISPR-Cas9 genome editing technology
• Discussion of the ethical and regulatory issues, as well as patent analysis, publication analysis and research funding in this area
• Profiles of key players in the industry, including Horizon Discovery, Thermo Fisher Scientific, CRISPR Therapeutics, Caribou Biosciences Inc., Editas Medicine and Vertex

Key Topics Covered:

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• Intended Audience
• Scope of Report
• Information Sources
• Methodology

Chapter 2 Summary and Highlights

• Key Drivers of Market Growth

Chapter 3 Current Genome Editing Technologies

• Overview
• History of Genome Editing
• Comparison of Genome Editing
• Discovery of CRISPR-Cas9
• Components of CRISPR-Cas Systems
• SgRNA
• Cas9 Nucleases
• How CRISPR-Cas Works
• Advantage of the CRISPR-Cas9 System
• Popularity of CRISPR Genome Editing
• Major Technological Issues
• Efficiency
• Specificity/Off-Target Effect
• Delivery Systems
• Immunogenicity Risk for Clinical Applications
• A New Genome Editing System: CRISPR-Cpf1
• Studies on Treating Diseases Using Genome Editing
• Impact of Genome Editing
• Future of CRISPR

Chapter 4 Applications of Genome Editing

• Introduction
• Academic Research
• Drug Discovery and Development
• Clinical Therapy
• Non-transgenic Breeding
• Diagnostics
• Other Applications

Chapter 5 Market Segmentation and Forecast

• Market Overview
• Major Players
• Market Segments by Region
• Market Segments by Application
• Market Segments by Technology
• Market Segments by Product Type

Chapter 6 Contract Services Market Analysis

• Market Overview
• Major Players
• Market Share and Projection
• Comparison with Products Segment

Chapter 7 Research Market Analysis

• Market Overview
• Market Share and Projections
• Patent Analysis
• Publication Analysis
• Research Funding Analysis

Chapter 8 Drug Development Market Analysis

• Market Overview
• Market Share and Forecast

Chapter 9 Agricultural Biotechnology Market Analysis

• Market Overview
• Market Share and Forecast

Chapter 10 Clinical Market Analysis

• Market Overview
• Market Share and Forecast
• Comparison with Non-clinical Market

Chapter 11 Competition Landscape and Opportunities

• Overview
• Growth Strategies
• Licensing and Agreements
• Collaborations with Big Biopharmaceutical Companies
• In-house R&D Program
• Startup
• Strategic Alliance and Joint Venture
• Focus on Specific Application Areas
• Venture Capital Funding
• Opportunities

Chapter 12 Factors Influencing the Genome Editing Market

• Introduction
• Driving Forces
• New Genome Editing Technologies and Related Advancements
• New Applications of Genome Editing
• Need for Precision Medicine
• Need for Improving Drug Discovery Process
• Increasing Demand for Synthetic Genes in Synthetic Biology
• Investments from Both Public and Private Sectors
• Increased R&D Expenditures in Related Industrial Sectors
• High Prevalence of Genetic Birth Disorders
• Concerns on Genetically Modified Crops
• Factors Limiting the Market's Growth
• Stringent Regulatory Frameworks and Time-Consuming Approval Processes
• Research Funding
• Patent Disputes
• Governmental Policies and Regulations
• Regulatory Uncertainty on Genome Edited Crops
• Ethical Issues

Chapter 13 Company Profiles

• Addgene
• Agilent Technologies Inc.
• Aldevron
• Allele Biotechnology
• American Type Culture Collection (Atcc)
• Applied Stemcell Inc.
• Arbor Biotechnologie Inc.
• Astrazeneca
• Atum (Dna2.0)
• Australian Bioresources Ltd.
• Axol Bioscience Ltd.
• Beam Therapeutics
• Biocytogen
• Bio-Rad Laboratories Inc.
• Biotools Co. Ltd.
• Bluebird Bio
• B-Mogen Biotechnologies Inc.
• Calyxt Inc.
• Canopy Biosciences
• Caribou Biosciences Inc.
• Caszyme
• Cellecta Inc.
• Cellectics S.A.
• Cibus
• Crispr Therapeutics
• Desktop Genetics
• Editas Medicine
• Genecopoeia
• Genewiz
• Genscript
• Horizon Discovery
• Innovative Genomics Initiative
• Intellia Therapeutics Inc.
• Integrated Dna Technologies
• Ixcells Biotechnologies
• Juno Therapeutics
• Lonza
• Mammoth Biosciences
• Merck Kgaa (Sigma-Aldrich)
• New England Biolabs
• Origene Technologies
• Precision Biosciences Inc.
• Recombinetics
• Regeneron Pharmaceutals Inc.
• Sangamo Biosciences
• Solentim Inc.
• Synthego
• System Biosciences
• Takara Bio Usa Inc. (Clontech)
• Thermo Fisher Scientific
• Toolgen Inc.
• Trans Genic Inc.
• Transomic Technologies Inc.
• Transposagen Biopharmaceuticals Inc.
• Vertex Pharmaceuticals Inc.
  

For more information about this report visit https://www.researchandmarkets.com/research/m6vg9q/global_genome?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Genomics

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.